These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 28900286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry.
    De Felice M, Renard J, Hudson R, Szkudlarek HJ, Pereira BJ, Schmid S, Rushlow WJ, Laviolette SR.
    J Neurosci; 2021 Jan 27; 41(4):739-750. PubMed ID: 33268546
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amelioration of cognitive impairments induced by GABA hypofunction in the male rat prefrontal cortex by direct and indirect dopamine D1 agonists SKF-81297 and d-Govadine.
    Auger ML, Meccia J, Phillips AG, Floresco SB.
    Neuropharmacology; 2020 Jan 01; 162():107844. PubMed ID: 31704272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons.
    Tseng KY, Lewis BL, Hashimoto T, Sesack SR, Kloc M, Lewis DA, O'Donnell P.
    J Neurosci; 2008 Nov 26; 28(48):12691-9. PubMed ID: 19036962
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
    Hudson R, Renard J, Norris C, Rushlow WJ, Laviolette SR.
    J Neurosci; 2019 Oct 30; 39(44):8762-8777. PubMed ID: 31570536
    [Abstract] [Full Text] [Related]

  • 10. Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation.
    Tanaka S.
    BMC Neurosci; 2008 Apr 25; 9():41. PubMed ID: 18439259
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area.
    Liu C, Fang X, Wu Q, Jin G, Zhen X.
    Neuropharmacology; 2015 Aug 25; 95():299-308. PubMed ID: 25882828
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex.
    Yuen EY, Yan Z.
    J Neurosci; 2009 Jan 14; 29(2):550-62. PubMed ID: 19144855
    [Abstract] [Full Text] [Related]

  • 15. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU.
    Biol Psychiatry; 1999 Sep 01; 46(5):616-26. PubMed ID: 10472415
    [Abstract] [Full Text] [Related]

  • 16. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J, Mengod G.
    Neuroscience; 2010 Nov 10; 170(4):1133-9. PubMed ID: 20727949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.